JPS5329935A - Lung function promoting medical composition - Google Patents

Lung function promoting medical composition

Info

Publication number
JPS5329935A
JPS5329935A JP10218177A JP10218177A JPS5329935A JP S5329935 A JPS5329935 A JP S5329935A JP 10218177 A JP10218177 A JP 10218177A JP 10218177 A JP10218177 A JP 10218177A JP S5329935 A JPS5329935 A JP S5329935A
Authority
JP
Japan
Prior art keywords
lung function
medical composition
function promoting
promoting medical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10218177A
Other languages
English (en)
Japanese (ja)
Inventor
Aanesuto Pitsutsu Nooman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS5329935A publication Critical patent/JPS5329935A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP10218177A 1976-08-26 1977-08-25 Lung function promoting medical composition Pending JPS5329935A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71790576A 1976-08-26 1976-08-26

Publications (1)

Publication Number Publication Date
JPS5329935A true JPS5329935A (en) 1978-03-20

Family

ID=24883964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10218177A Pending JPS5329935A (en) 1976-08-26 1977-08-25 Lung function promoting medical composition

Country Status (19)

Country Link
JP (1) JPS5329935A (cs)
AU (1) AU503877B2 (cs)
BE (1) BE858094A (cs)
CA (1) CA1092028A (cs)
DE (1) DE2737735C3 (cs)
DK (1) DK354377A (cs)
FR (1) FR2362629A1 (cs)
GB (1) GB1541991A (cs)
GR (1) GR68687B (cs)
HK (1) HK30981A (cs)
IE (1) IE45768B1 (cs)
IL (1) IL52588A (cs)
LU (1) LU78022A1 (cs)
MY (1) MY8100263A (cs)
NL (1) NL170367C (cs)
NZ (1) NZ184746A (cs)
PT (1) PT66866B (cs)
SE (1) SE7708307L (cs)
ZA (1) ZA774474B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63156327U (cs) * 1987-04-02 1988-10-13

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63156327U (cs) * 1987-04-02 1988-10-13

Also Published As

Publication number Publication date
DE2737735B2 (de) 1979-03-08
PT66866B (en) 1978-12-29
FR2362629B1 (cs) 1980-07-11
NZ184746A (en) 1980-02-21
NL7708732A (nl) 1978-02-28
DK354377A (da) 1978-02-27
IL52588A (en) 1980-07-31
ZA774474B (en) 1978-06-28
DE2737735A1 (de) 1978-03-02
IE45768B1 (en) 1982-11-17
DE2737735C3 (de) 1979-10-25
AU2741277A (en) 1979-02-01
NL170367C (nl) 1982-11-01
LU78022A1 (fr) 1979-05-23
CA1092028A (en) 1980-12-23
MY8100263A (en) 1981-12-31
IE45768L (en) 1978-02-28
BE858094A (fr) 1978-02-27
AU503877B2 (en) 1979-09-27
GB1541991A (en) 1979-03-14
HK30981A (en) 1981-07-10
FR2362629A1 (fr) 1978-03-24
SE7708307L (sv) 1978-02-27
PT66866A (en) 1977-08-01
IL52588A0 (en) 1977-10-31
GR68687B (cs) 1982-02-01

Similar Documents

Publication Publication Date Title
JPS52134026A (en) Medical composition
JPS52151712A (en) Composition for medical preparation
YU131376A (en) Medical fluid-container
JPS5386047A (en) Oral antiibacterial composition
JPS5289700A (en) Medical composition having antiiulcer activity
JPS542341A (en) Medical composition
JPS5215826A (en) Medical composition
JPS5428829A (en) Antiithrombosis medical composition
JPS5334930A (en) Medical composition
JPS5386046A (en) Oral antiibacterial composition
JPS5315428A (en) Medical composition
JPS5470432A (en) Medical composition
JPS5540677A (en) Medical composition
JPS5444389A (en) Inhaler
JPS5444390A (en) Inhaler
JPS5329935A (en) Lung function promoting medical composition
JPS5326448A (en) Ventilator
JPS5359035A (en) Medical composition
JPS5381610A (en) Antiicancer medical composition
JPS52139731A (en) Medical composition
JPS542335A (en) Medical composition
JPS539308A (en) Fumigant composition
JPS5363369A (en) Medical composition
JPS52136922A (en) Antiiallergy medical composition
JPS5470429A (en) Medical composition